A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit
Journal of Antimicrobial Chemotherapy · 2026
DOI: 10.1093/jac/dkag110 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Sarah Hendrickx und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, Wilrijk (Antwerp) 2610, Belgium. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Drug Discovery, Drug Development, Kinetoplastida. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 162 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek, Swedish Research Council Formas, Kempe Foundations.
Abstract (Originalsprache)
Given the medical importance and challenges related to kinetoplastid diseases, a strategic roadmap is needed for the identification of high-quality leads and drug development candidates. Within the aim to deliver more compelling proof-of-concept read-outs, this part proposes a systematic flow-chart of laboratory experiments and decision criteria, focusing on African trypanosomiasis, Chagas disease and visceral and cutaneous leishmaniasis. Next to precision experimental design and reporting, an overview is provided of various complementary laboratory models reproducing kinetoplastid infection and disease. Technical aspects of conventional in vitro and in vivo approaches and, more recently, in silico methods are presented with reference to specific preclinical R&D stages from ‘hit finding’ to ‘profiling of a confirmed hit’, covering the expertise areas of medicinal chemistry, primary pharmacology, (eco)toxicology, pharmacokinetics and pharmaceutics (Figure 1).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Microbiology, Parasitology and Hygiene, University of Antwerp, Wilrijk (Antwerp) 2610, Belgium.
- Department of Wildlife, Fish, and Environmental Studies, Swedish University of Agricultural Sciences, Umeå 907 36, Sweden.
- Laboratory of Adaptive Biodynamics, Research Unit of Environmental and Evolutionary Biology, Institute of Life, Earth, and Environment, University of Namur, Namur 5000, Belgium.
- Department of Zoology, Stockholm University, Stockholm 114 18, Sweden.
- School of Biological Sciences, Monash University, Clayton Victoria 3800, Australia.
- Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan 20133, Italy.
ORCID-Profile: Katrien Van Bocxlaer, Guy Caljon
Förderung
- Fonds Wetenschappelijk Onderzoek
- Swedish Research Council Formas
- Kempe Foundations
Zitieren
APA
Hendrickx, S., Ilbeigi, K., Thoré, E. S. J., Bertram, M. G., Calvo-Alvarez, E., Cintesun, S., Olías-Molero, A. I., Corral, M. J., Mateo-Barrientos, M., Estaquier, J., Pomel, S., Alunda, J. M., Gul, S., Van Bocxlaer, K., Frézard, F., Tavares, J., Cordeiro Da Silva, A., Costi, M. P., Maes, L., & Caljon, G. (2026). A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag110
Vancouver
Hendrickx S, Ilbeigi K, Thoré ESJ, Bertram MG, Calvo-Alvarez E, Cintesun S, et al. A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag110
BibTeX
@article{Hendrickx2026,
author = {Hendrickx, Sarah and Ilbeigi, Kayhan and Thoré, Eli S J and Bertram, Michael G and Calvo-Alvarez, Estefanía and Cintesun, Sener and Olías-Molero, Ana Isabel and Corral, María Jesús and Mateo-Barrientos, Marta and Estaquier, Jérôme and Pomel, Sébastien and Alunda, José María and Gul, Sheraz and Van Bocxlaer, Katrien and Frézard, Frédéric and Tavares, Joana and Cordeiro Da Silva, Anabela and Costi, Maria Paola and Maes, Louis and Caljon, Guy},
title = {A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 2: from molecule to confirmed hit},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
doi = {10.1093/jac/dkag110}
}
EUVIMED